HETEROARYL DERIVATIVES AS PD1/PD-L1 INHIBITORS FOR THE TREATMENT OF HBV AND CANCER
Publication
EP4313968A2
Kind: A2
Mar 18, 2026
Applicants
Arbutus Biopharma Corporation
Inventors
AHUJA, Vijay, COLE, Andrew G., DORSEY, Bruce D., FAN, Yi, HEFFERNAN, Gavin D., KAKARLA, Ramesh, KULTGEN, Steven G., NGUYEN, Duyan, OZTURK, Seyma, QUINTERO, Jorge, SOFIA, Michael J.
IPC Classifications
C07D 213/64 20060101AFI20260115BHEP
C07D 213/69 20060101ALI20260115BHEP
C07D 213/74 20060101ALI20260115BHEP
C07D 213/81 20060101ALI20260115BHEP
C07D 401/10 20060101ALI20260115BHEP
C07D 401/14 20060101ALI20260115BHEP
C07D 401/12 20060101ALI20260115BHEP
C07D 403/14 20060101ALI20260115BHEP
C07D 405/14 20060101ALI20260115BHEP
C07D 409/14 20060101ALI20260115BHEP
C07D 413/14 20060101ALI20260115BHEP
C07D 417/14 20060101ALI20260115BHEP
C07D 471/04 20060101ALI20260115BHEP
C07D 487/04 20060101ALI20260115BHEP
C07D 487/10 20060101ALI20260115BHEP
C07D 491/107 20060101ALI20260115BHEP
C07D 519/00 20060101ALI20260115BHEP
A61P 31/12 20060101ALI20260115BHEP
A61P 31/14 20060101ALI20260115BHEP
A61P 31/20 20060101ALI20260115BHEP
A61P 35/00 20060101ALI20260115BHEP
A61K 31/53 20060101ALN20260115BHEP
A61K 31/395 20060101ALN20260115BHEP
A61K 31/444 20060101ALN20260115BHEP
A61K 31/519 20060101ALN20260115BHEP
A61K 31/553 20060101ALN20260115BHEP
A61K 31/4545 20060101ALN20260115BHEP
A61K 31/4709 20060101ALN20260115BHEP
A61K 31/4725 20060101ALN20260115BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR